TRAIL, a TNF-related apoptosis-inducing ligand, was shown to induce apoptosis selectively in cancer cells, with little or no toxicity in vivo (cynomolgus monkeys and chimpanzees) [193,194] or in Phase I clinical trials [195]. The gene discussed is TNFSF10; the disease is cancer.